Disclosures for "Effect of complement C3 inhibition with pegcetacoplan in an iPSC-derived ALS neuromuscular junction model of neuroinflammation")
-
Dr. Li has received personal compensation for serving as an employee of Apellis Pharmaceuticals, Inc.
-
Dr. Smith has stock in Hesperos, Inc..
-
Dr. Skinner has received personal compensation for serving as an employee of Hesperos Inc.
-
Ashley Robertson has received personal compensation for serving as an employee of Hesperos, Inc.. Ashley Robertson has stock in Hesperos, Inc..
-
Ms. Lenkiu has received personal compensation for serving as an employee of Hesperos inc`.
-
Ms. Cannon has received personal compensation for serving as an employee of Hesperos, Inc.. Ms. Cannon has stock in Hesperos, Inc..
-
Ms. Martinez has received personal compensation for serving as an employee of Hesperos Inc.
-
Hannah Hanson has received personal compensation for serving as an employee of Hesperos.
-
Dr. Hickman has stock in Hesperos, Inc. Dr. Hickman has received research support from Hesperos, Inc.
-
David Eyerman has received personal compensation for serving as an employee of Apellis Pharmaceuticals . David Eyerman has stock in Apellis Pharmaceuticals . David Eyerman has stock in Fulcrum Therapeutics . David Eyerman has stock in Alkermes . David Eyerman has stock in Denali Therapeutics. David Eyerman has stock in Beam Therapeutics. David Eyerman has stock in Passage Bio .